Marksans Pharma Approved for Metformin Solution in UK

  Published 10 months ago

Marksans Pharma received UK regulatory approval to market a Metformin Hydrochloride oral solution for type 2 diabetes, addressing patients with swallowing difficulties. This expands their generic pharmaceutical portfolio globally.

  • Approved for oral liquid Metformin in the UK.
  • Marksans Pharma has USFDA, UKMHRA, & TGA approvals.
  • The company focuses on diverse therapeutic segments.

You might like these

RBL Bank Stock Climbs 3.7%, Citi Hikes Target

NSDL IPO Opens on July 30

Amazon's India Quick-Commerce Challenge

Infosys & Adobe AI Collaboration Boosts Marketing

Vijaya Diagnostic Q1 Profit Surges

Solar, Battery Plant Funding Overview

India Manufacturing Hits 17-Year High

News that matters the most ⚡